The Marcus Center for Cellular Cures (MC3) provides bench to bedside cell and gene therapy product development. Resources available include the Carolinas Cord Blood Bank, providing source material, the Research and Development Laboratory, the Product Development Laboratory, the GMP Laboratories, Regulatory and Quality team, and the Clinical Trials Team. MC3 manufactures two FDA licensed products: RETHYMIC (allogeneic processed thymic tissue-agdc), and DUCORD (HPC, cord blood).